1. Home
  2. AL vs NUVL Comparison

AL vs NUVL Comparison

Compare AL & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Air Lease Corporation

AL

Air Lease Corporation

HOLD

Current Price

$64.71

Market Cap

7.3B

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$102.83

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AL
NUVL
Founded
2010
2017
Country
United States
United States
Employees
160
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
8.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AL
NUVL
Price
$64.71
$102.83
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$62.50
$135.33
AVG Volume (30 Days)
1.7M
444.0K
Earning Date
01-01-0001
05-27-2026
Dividend Yield
1.36%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.78
N/A
Revenue Next Year
$5.58
$1,064.25
P/E Ratio
$6.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.25
$55.54
52 Week High
$64.97
$113.02

Technical Indicators

Market Signals
Indicator
AL
NUVL
Relative Strength Index (RSI) 52.23 50.12
Support Level $63.44 $98.65
Resistance Level $64.97 $107.13
Average True Range (ATR) 0.11 4.31
MACD -0.03 -0.08
Stochastic Oscillator 19.70 55.75

Price Performance

Historical Comparison
AL
NUVL

About AL Air Lease Corporation

Air Lease Corp is an aircraft leasing company based in the United States. It is engaged in the modern, fuel-efficient new technology commercial jet aircraft directly from aircraft manufacturers and leasing those aircraft to airlines throughout the world to generate attractive returns on equity. The company also sells aircraft from its fleet to third parties, including other leasing companies, financial services companies, airlines, and other investors, and offers fleet management services to investors and owners of aircraft portfolios for a management fee. Geographically, it derives a maximum of its revenue from the Europe and the rest from Asia Pacific, Middle East and Africa, Central America, South America, Mexico, the United States, and Canada.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: